These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8342392)

  • 21. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy.
    Balducci R; Toscano V; Pasquino AM; Mangiantini A; Municchi G; Armenise P; Terracina S; Prossomariti G; Boscherini B
    Eur J Endocrinol; 1995 Jan; 132(1):42-6. PubMed ID: 7850009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical application of luteinizing hormone releasing hormone agonist and its impact on bone metabolism].
    Zhang M; He Y; Cao S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):398-401. PubMed ID: 7587574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
    Ragnar Agnarsson H; Johannsson G; Ragnarsson O
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration.
    Mann DR; Rudman CG; Akinbami MA; Gould KG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1263-9. PubMed ID: 1592869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
    Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
    J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
    Rodríguez-Arnao J; James I; Jabbar A; Trainer PJ; Perrett D; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.
    Degerblad M; Bengtsson BA; Bramnert M; Johnell O; Manhem P; Rosén T; Thorén M
    Eur J Endocrinol; 1995 Aug; 133(2):180-8. PubMed ID: 7655642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.
    Kann P; Piepkorn B; Schehler B; Andreas J; Lotz J; Prellwitz W; Beyer J
    Clin Endocrinol (Oxf); 1998 May; 48(5):561-8. PubMed ID: 9666867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men].
    Kozakowski J; Papierska L; Krassowski J; Zgliczyński S
    Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.
    Barake M; Klibanski A; Tritos NA
    J Clin Endocrinol Metab; 2014 Mar; 99(3):852-60. PubMed ID: 24423364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
    Kužma M; Binkley N; Bednárová A; Killinger Z; Vaňuga P; Payer J
    Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced bone mineral density in patients with adult onset growth hormone deficiency.
    Holmes SJ; Economou G; Whitehouse RW; Adams JE; Shalet SM
    J Clin Endocrinol Metab; 1994 Mar; 78(3):669-74. PubMed ID: 8126140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.
    Vandeweghe M; Taelman P; Kaufman JM
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):409-15. PubMed ID: 8287567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.
    Sartorio A; Ortolani S; Conti A; Cherubini R; Galbiati E; Faglia G
    J Endocrinol Invest; 1996 Sep; 19(8):524-9. PubMed ID: 8905475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.